

The Pharma Industry registered 8% growth in Q3 2024. Some of the key trends of Pharma Industry for Q3 2024 are as below –
Chronic therapies (10%) reflected better growth than Acute therapies (7%).
Cardiac, antineoplastics, and urology led in terms of growth amongst Chronic therapies. Gastro and Derma led in terms of growth amongst Acute therapies.
Number of new launches have decreased by 9% in 2024 as compared to 2023.
Download the presentation for more detailed insights.